GLP-1 diabetes drugs linked to increased risk of hair loss Use of glucagon-like peptide-1 (GLP-1) receptor agonists used to treat type 2 diabetes and obesity are associated with an increased risk of hair loss (alopecia) in adults with type 2 diabetes, finds a study published by The BMJ today
As for my injection site of choice, I chose the upper buttocks (gluteus medius) mainly because of the size of the muscle and the relative ease I have accessing it
Cancer Statistics Working Group
These could include: If your GES test results are abnormal, your provider may recommend an electrogastrogram (EGG), which is a test that measures the electrical activity of your stomach muscles
For those comparing topical actives, our article on peptides versus retinol and our cosmetic peptides guide provide useful context on how copper peptides fit into a broader topical strategy
In 2024, Blue Cross Blue Shield of Michigan, the states largest nonprofit insurer, and North Carolinas state employee public insurance agency stopped covering the drugs for weight loss, saying the cost increased premiums for all customers